CES1 Antibodies

Santa Cruz Biotechnology features a diverse variety of CES1 monoclonal antibodies for advanced research in biochemistry and molecular biology. CES1 Antibodies are optimized for various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Carboxylesterase 1 (CES1) plays a crucial role in the metabolism of drugs and xenobiotics, contributing to the hydrolysis of ester and amide bonds. CES1 is significant in pharmacokinetics, influencing drug efficacy and toxicity, and is involved in the detoxification processes within the liver. Understanding CES1 function is essential for developing therapeutic strategies and improving drug design. CES1 research has revealed important insights into drug metabolism and toxicology. Ongoing studies continue to uncover new aspects of CES1 activity in various physiological processes. Research utilizing CES1 monoclonal antibodies has enhanced our understanding of drug-enzyme interactions and metabolic pathways. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge of CES1 and its impact on drug development and therapeutic applications.